Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $475.36 USD
Change Today -4.73 / -0.99%
Volume 539.4K
REGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Munich
As of 1:12 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at regeneron pharmaceuticals (REGN)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Leonard Schleifer M.D., Ph.D.109 RelationshipsCo-Founder, Chief Executive Officer, President, Executive Director and Ex-Officio Member of Technology CommitteeChief Executive Officer61
Alfred Gilman M.D., Ph.D.11 RelationshipsCo-Founder, Independent Director, Chairman of Corporate Governance & Compliance Committee and Member of Technology CommitteeTop Key Executive72
George Yancopoulos M.D., Ph.D.24 RelationshipsChief Scientific Officer, Director, Member of Technology Committee and President of Regeneron Research LaboratoriesUnit President54

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Pindaros Vagelos M.D. 108 RelationshipsChairman of the BoardRegeneron Pharmaceuticals, Inc.84
George Sing 17 RelationshipsMember of the Board of DirectorsStemnion, Inc.65
Michael Brown M.D. 25 RelationshipsMember of the Board of DirectorsPeloton Therapeutics, Inc.73
Marc Tessier-Lavigne Ph.D. 83 RelationshipsMember of the Board of DirectorsJuno Therapeutics Inc.54
Charles Baker J.D. 11 RelationshipsMember of the Board of DirectorsThe Liposome Company, Inc.81
Joseph Goldstein M.D. 109 RelationshipsMember of the Board of DirectorsThe Column Group LLC74
Arthur Ryan 84 RelationshipsMember of the Board of DirectorsPrudential do Brasil Seguros de Vida S.A.71
Christine Poon 46 RelationshipsMember of the Board of DirectorsKoninklijke Philips N.V62
Robert Ingram 211 RelationshipsMember of the Board of DirectorsJennerex Biotherapeutics, Inc.72
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $475.06 USD -5.03

REGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMarin Pharmaceutical Inc $117.07 USD -3.21
Incyte Corp $102.18 USD -5.16
Pharmacyclics Inc $256.58 USD -0.01
UCB SA €69.23 EUR +0.21
Vertex Pharmaceuticals Inc $128.75 USD -4.45
View Industry Companies
 

Industry Analysis

REGN

Industry Average

Valuation REGN Industry Range
Price/Earnings 100.0x
Price/Sales 17.3x
Price/Book 19.2x
Price/Cash Flow 139.7x
TEV/Sales 16.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.